Phase III study of intraperitoneal cisplatin-intravenous cyclophosphamide versus intravenous cisplatin-intravenous cyclophosphamide in patients with optimal disease stage III ovarian cancer: A SWOG-GOG-ECOG Intergroup study

International Journal of Gynecological Cancer

Volumn 6, Issue 5 SUPPL. 1, 1996, Pages 28-29

  Alberts, D S ^a   Liu, P Y ^a   Hannigan, E V ^a   O'Toole, R ^a   Williams, S D ^a   Young, J A ^a   Franklin, E W ^a   Clarke Pearson, D L ^a   Malviya, V K ^a   Dubeshter, B ^a   Hoskins, W J ^a   Adelson, M D ^a   Alvarez, R D ^a   O'Sullivan, J ^a   Garcia, D J ^a   Sparks, D B ^a   Quade, J ^a   Rothenberg, M L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE;

ABDOMINAL HYSTERECTOMY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HEARING LOSS; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; NEUTROPENIA; OVARIECTOMY; OVARY CANCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 9444272224     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)